Tip: Index histories & All-time highs

Key Market Indicator:
Welcome our new Research Provider
In the Research & Ratings section, you can access assessments from renowned analyst firms that specialize in the due diligence and valuation of companies that are generally listed on the stock exchange. Starting from the research reports, you can access further research tools and information with just a few mouse clicks, which offer you additional options for obtaining and assessing information.
Thu, 16.12.2021       Deutsche Effecten- und Wechsel- Beteiligungsgesellschaft AG
First Berlin Equity Research GmbH DE0008041005

First Berlin Equity Research hat ein Research Update zu Deutsche Effectenund Wechsel- Beteiligungsgesellschaft AG (ISIN: DE0008041005) veröffentlicht. Analyst Christian Orquera bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 2,50 auf EUR 2,90. Zusammenfassung: In der ersten Dezemberhälfte 2021 hat die Deutsche [ … ]
Technical analysis
To the publication
Mon, 13.12.2021       Deutsche Rohstoff AG
First Berlin Equity Research GmbH DE000A0XYG76

First Berlin Equity Research hat ein Research Update zu Deutsche Rohstoff AG (ISIN: DE000A0XYG76) veröffentlicht. Analyst Simon Scholes bestätigt seine BUY-Empfehlung und erhöht das Kursziel von EUR 28,00 auf EUR 31,00. Zusammenfassung: Das Ergebnis des ersten Produktionsmonats der zwei Meilen langen horizontalen Buster-Bohrung de [ … ]
Technical analysis
To the publication
Mon, 13.12.2021       Aspermont Limited
GBC AG AU000000ASP3

Preliminary FY2021 shows positive Net Profit After Tax FY2021 preliminary report shows continued growth As per their preliminary numbers, the company has delivered on all their guidance: - Overall growth - Subscriptions growth rate to go back to pre-Covid-19 levels - Growth in audience - High growth in new products - Continue [ … ]
Technical analysis
To the publication
Fri, 10.12.2021       HAEMATO AG
GBC AG DE000A289VV1

In operational terms, HAEMATO AG is heading for a record year following the acquisition of M1 Aesthetics GmbH. In addition, the expansion of their private label business is increasingly coming into focus. In this regard, the company plans to expand its portfolio with a botulinum toxin product under its own brand. GBC analyst Cosmin Filker spoke wi [ … ]
Technical analysis
To the publication
Thu, 09.12.2021       EasyMotionSkin Tec AG
GBC AG LI1147158318

Successful listing of EasyMotionSkin Tec AG on the m:access of the Munich Stock Exchange On 09.12.2021 EasyMotionSkin Tec AG was successfully listed on the m:access of the Munich Stock Exchange. The initial share price is 14.50 EUR. According to the management, no extensive capital market transactions are planned in the near future. The EasyMo [ … ]
Technical analysis
To the publication
Thu, 09.12.2021       Haemato AG
First Berlin Equity Research GmbH DE000A289VV1

First Berlin Equity Research hat ein Research Update zu Haemato AG (ISIN: DE000A289VV1) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 50,00. Zusammenfassung: Haemato hat Q3-Kennzahlen gemeldet, die eine anhaltend gute Geschäftsdynamik zeigten, angeführt von einem  [ … ]
Technical analysis
To the publication
Mon, 06.12.2021       PSI AG
First Berlin Equity Research GmbH DE000A0Z1JH9

First Berlin Equity Research hat ein Research Update zu PSI AG (ISIN: DE000A0Z1JH9) veröffentlicht. Analyst Simon Scholes bestätigt seine ADD-Empfehlung und erhöht das Kursziel von EUR 33,00 auf EUR 49,00. Zusammenfassung: Die Parteien der neuen deutschen Regierung (SPD, Grüne und Freie Demokraten) haben sich darauf geeinigt, [ … ]
Technical analysis
To the publication
Mon, 06.12.2021       Defence Therapeutics Inc.
GBC AG CA24463V1013

'We can work on any disease and adapt to any emergent pandemic such as the one related to SARS-CoV2' In its current letter to shareholders, Defence Therapeutics reports the successful completion of its protein-based COVID vaccine (AccuVAC-PT001) toxicology studies in non-rodent rabbit model. The AccuVAC-PT001 vaccine is an injectable vaccine cap [ … ]
Technical analysis
To the publication
Thu, 02.12.2021       M1 Kliniken AG
First Berlin Equity Research GmbH DE000A0STSQ8

First Berlin Equity Research hat am 02.12.2021 die Coverage von M1 Kliniken AG (ISIN: DE000A0STSQ8/ Bloomberg: M12 GR) wieder aufgenommen. Analyst Ellis Acklin stuft die Aktie mit einem Buy-Rating ein, bei einem Kursziel von EUR 14,00. Zusammenfassung: Wir nehmen die Coverage der M1 Kliniken AG (M1) mit einem Buy-Rating und einem Kursziel von &e [ … ]
Technical analysis
To the publication
Thu, 25.11.2021       Aroundtown SA
First Berlin Equity Research GmbH LU1673108939

First Berlin Equity Research hat ein Research Update zu Aroundtown SA (ISIN: LU1673108939) veröffentlicht. Analyst Ellis Acklin bestätigt seine BUY-Empfehlung und bestätigt sein Kursziel von EUR 8,60. Zusammenfassung: Der Q3-Bericht lag nahe an unseren Zielen und war von der laufenden Veräußerung von nicht zum Kerngesch [ … ]
Technical analysis Trade The News (TTN)
To the publication

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

Legend/Explanation
The newswire feed is updated several times a day. To make sure you don't miss any news, please check back here often. If you are curious about a headline or want to find out more about a publication, click on it to go to the preview and click again to go to the full news item.
About the newsfeed
#1
Where does the information come from?

The information is provided as part of a content partnership by one of Europe's leading news data providers, the Munich-based EQS Group.

#2
Will editorial changes be made?
The portal site is part of the EQS-Newswire distribution network. The information is provided 'as is'. No editorial adjustments are made. The detailed views are enriched with additional information in order to offer interested investors further research options.
#3
From which news source does the information originate?
As a rule, it is the companies themselves that provide information, either through their own public relations work or via partner agencies. Due to the wide reach of the EQS distribution network and the associated multiplier effects, this service is often used to reach interested parties quickly and in a targeted manner. The EQS Group counts almost all listed companies among its customers.
#4
Are the messages provided in real time?

The data feeds are updated at regular intervals. You can obtain the latest information directly from EQS if required. Simply follow the link below.

#5
Are there plans to expand the scope of the news?

If investor-relevant topics are involved, it is possible to connect additional data providers. In Q1/2024, mwb Research was added to the information offering in the rating area.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Tuesday, 08.04.2025, Calendar Week 15, 98th day of the year, 267 days remaining until EoY.